Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 2 minute read Healthcare Industry News Avicenna.AI’s AI tool CINA-CSpine receives FDA clearance for cervical spine fracture detection Avicenna.AI has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its new artificial intelligence… byPallavi MadhirajuSeptember 22, 2024